# ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis

> **NCT03404258** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 50 (estimated)

## Conditions studied

- Single-ventricle
- Pulmonary Vascular Resistance Abnormality
- Superior Cavo-Pulmonary Anastomosis
- Endothelin
- Metabolomics

## Interventions

- **OTHER:** Research Blood Sampling

## Key facts

- **NCT ID:** NCT03404258
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404258, "ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03404258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*